The Chemical Profile of Orciprenaline (CAS 586-06-1): A Manufacturer's Overview
Understanding the precise chemical nature of pharmaceutical ingredients is fundamental to their effective and safe application. Orciprenaline, identified by its CAS number 586-06-1, possesses a distinct chemical profile that underpins its therapeutic utility as a bronchodilator. NINGBO INNO PHARMCHEM CO.,LTD., a leading pharmaceutical ingredient manufacturer in China, provides insights into the chemical aspects of Orciprenaline and its role in respiratory health.
The chemical structure of Orciprenaline is C11H17NO3, with a molecular weight of 211.26 g/mol. This composition classifies it as a phenylethanolamine derivative. Its physical form is typically a solid powder, which is convenient for formulation into various dosage forms. The precise quality standards for Orciprenaline, such as USP, BP, and FCC, are critical for its use in pharmaceuticals. These standards ensure purity, identity, and strength, guaranteeing that the ingredient will perform as expected in drug products.
Manufacturing Orciprenaline involves complex chemical synthesis pathways. NINGBO INNO PHARMCHEM CO.,LTD. leverages advanced synthesis techniques and stringent quality control measures to produce Orciprenaline that meets these high standards. Our expertise as a China-based manufacturer allows us to manage the production efficiently, ensuring a reliable supply for our global clientele. For companies looking to buy Orciprenaline, understanding these manufacturing nuances highlights the importance of partnering with a qualified supplier.
The chemical properties of Orciprenaline are directly linked to its pharmacological activity as a beta-2 adrenergic agonist. Its specific molecular structure enables it to interact with beta-2 receptors, initiating the cascade that leads to bronchodilation. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing Orciprenaline that not only meets chemical specifications but also contributes to the development of effective treatments for asthma and COPD. By prioritizing quality and technical expertise, we support the pharmaceutical industry's mission to improve patient lives through reliable medication.
The chemical structure of Orciprenaline is C11H17NO3, with a molecular weight of 211.26 g/mol. This composition classifies it as a phenylethanolamine derivative. Its physical form is typically a solid powder, which is convenient for formulation into various dosage forms. The precise quality standards for Orciprenaline, such as USP, BP, and FCC, are critical for its use in pharmaceuticals. These standards ensure purity, identity, and strength, guaranteeing that the ingredient will perform as expected in drug products.
Manufacturing Orciprenaline involves complex chemical synthesis pathways. NINGBO INNO PHARMCHEM CO.,LTD. leverages advanced synthesis techniques and stringent quality control measures to produce Orciprenaline that meets these high standards. Our expertise as a China-based manufacturer allows us to manage the production efficiently, ensuring a reliable supply for our global clientele. For companies looking to buy Orciprenaline, understanding these manufacturing nuances highlights the importance of partnering with a qualified supplier.
The chemical properties of Orciprenaline are directly linked to its pharmacological activity as a beta-2 adrenergic agonist. Its specific molecular structure enables it to interact with beta-2 receptors, initiating the cascade that leads to bronchodilation. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing Orciprenaline that not only meets chemical specifications but also contributes to the development of effective treatments for asthma and COPD. By prioritizing quality and technical expertise, we support the pharmaceutical industry's mission to improve patient lives through reliable medication.
Perspectives & Insights
Nano Explorer 01
“The chemical properties of Orciprenaline are directly linked to its pharmacological activity as a beta-2 adrenergic agonist.”
Data Catalyst One
“Its specific molecular structure enables it to interact with beta-2 receptors, initiating the cascade that leads to bronchodilation.”
Chem Thinker Labs
“is committed to providing Orciprenaline that not only meets chemical specifications but also contributes to the development of effective treatments for asthma and COPD.”